Clinical Trial Update: Daratumumab-bortezomib-dexamethasone (Dara-VCd) vs Bortezomib-Thalidomide-Dexamethasone (VTd), Then Maintenance With Ixazomib (IXA) or IXA-Dara [Phase 2]

View source ↗

Summary

Phase 2 trial update comparing Daratumumab-bortezomib-dexamethasone (Dara-VCd) against bortezomib-thalidomide-dexamethasone (VTd), followed by ixazomib maintena…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)
• DEXAMETHASONE (Dexamethasone)
• Daratumumab (daratumumab)
• Thalidomide (thalidomide)
• ixazomib (ixazomib)

Snippet

Sponsor: Stichting European Myeloma Network | Conditions: Multiple Myeloma | Phase 2 | Status: ACTIVE_NOT_RECRUITING